Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
GLP-1RAs: Mechanism of Action and Role in HFpEF Management
Author(s): Magdy Abdelhamid , Mostafa M Abdrabou , Emanuel Faris , et al Added: 7 months ago

Heart Failure
The True Obesity Paradox: Obese and Malnourished?
Author(s): Mohammed El-Sheikh , Nora Olsen El Caidi , Aginsha Kandiah , et al Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Simple Risk Stratification Could Optimise Heart Failure Follow-Up and Outcomes
Added: 10 months ago Source:  Radcliffe Cardiology
A new nationwide cohort study from France suggests that a simple risk stratification tool based on administrative data could help tailor cardiologist follow-up for patients with heart failure (HF), potentially improving survival and optimising resource use. The study found that 40% of patients with HF do not have an annual cardiology consultation, regardless of their disease severity.¹The French… View more

Digital Health

Guidelines & Statements
New Challenges in Heart Failure: An Expert Assessment of How Real-World Observations Are Changing Our Practice
Author(s): Giuseppe Rosano , John R Teerlink , Koichiro Kinugawa Added: 1 year ago
This comprehensive video series has been designed to enhance your understanding of heart failure (HF) management. Through expert discussions, we explore the real-world adoption of novel guideline-directed medical therapies (GDMTs) and their impact on patient care. We also delve into the benefits of natriuretic peptide (NP) testing, highlighting how it aids in more accurate and rapid diagnosis,… View more

Heart Failure
EASD 25: EMPIRE-PREVENT: Metabolic Effects of Empagliflozin in Patients at Risk of Heart Failure
Author(s): Camilla Andersen Added: 9 months ago
EASD Congress 2025 - Dr Camilla Andersen (The University of Western Australia, Perth, AU) joins us to discuss findings from the EMPIRE-PREVENT: Metabolic study, investigating the metabolic effects of empagliflozin in elderly and obese patients at high risk of developing heart failure (HF).This randomized controlled trial evaluated 165 patients aged 60–84 years with obesity (BMI >28kg/m²) and… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Heart Failure's Global Economic Toll Exceeds $284 Billion, New Study Finds
Added: 10 months ago Source:  Radcliffe Cardiology
The global economic burden of heart failure (HF) reached an estimated $284.17 billion in 2021, highlighting a substantial and growing financial strain on healthcare systems and societies worldwide. A new systematic review reveals that indirect costs, such as productivity loss, now account for over half of this total, signalling a significant shift in the economic impact of the condition… View more

Guidelines & Statements

Heart Failure
VAC in HFpEF: Trends and Challenges
Author(s): Tianzong Li , Yiran Luo , Lina Zhao , et al Added: 6 months ago

Heart Failure

Imaging & Diagnostics
Coronary Revascularisation in HFrEF
Author(s): Bernhard Haring , Michael Böhm Added: 2 years ago

Prevention & Chronic Conditions

Heart Failure
Autophagy and Endoplasmic Reticulum Stress in HFpEF
Author(s): Citrawati Dyah Kencono Wungu , Hendri Susilo , Cleodylon Reinard Susanto , et al Added: 4 months ago

MI/ACS

Prevention & Chronic Conditions
HFpEF in Patients Living with COPD
Author(s): Nadirah Abd Wahid , Aisya Natasya Musa , Sazzli Kasim , et al Added: 4 months ago

Heart Failure

Imaging & Diagnostics